Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionPnc Financial Services Group, Inc.
Latest Disclosed Ownership18,636 shares
Latest Disclosed Value $ 434,218
Pnc Financial Services Group, Inc. reports 11.64% decrease in ownership of HVE / Innoviva, Inc.

On May 8, 2026 - Pnc Financial Services Group, Inc. filed a 13F-HR form disclosing ownership of 18,636 shares of Innoviva, Inc. (DE:HVE) valued at $372,720 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 21,092 shares of Innoviva, Inc.. This represents a change in shares of -11.64% during the quarter. The current value of the position is $357,811 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F INNOVIVA COM 45781M101 18,636 -2,456 -11.64 434 3.09 0.0003
2026-02-06 2025-12-31 13F INNOVIVA COM 45781M101 21,092 -232 -1.09 422 8.23 0.0002
2025-11-07 2025-09-30 13F INNOVIVA COM 45781M101 21,324 -1,643 -7.15 389 -15.62 0.0002
2025-08-08 2025-06-30 13F INNOVIVA COM 45781M101 22,967 -341 -1.46 461 9.24 0.0003
2025-05-09 2025-03-31 13F INNOVIVA COM 45781M101 23,308 84 0.36 423 4.98 0.0002
2025-02-07 2024-12-31 13F INNOVIVA COM 45781M101 23,224 -13,845 -37.35 403 -43.78 0.0003
2024-11-08 2024-09-30 13F INNOVIVA COM 45781M101 37,069 -5,063 -12.02 716 3.62 0.0005
2024-08-09 2024-06-30 13F INNOVIVA COM 45781M101 42,132 3,162 8.11 691 16.36 0.0005
2024-05-10 2024-03-31 13F INNOVIVA COM 45781M101 38,970 38,053 4,149.73 594 19,666.67 0.0004
2024-03-22 2023-12-31 13F/A-1 THESEUS PHARMACEUTICALS COM 88369M101 917 -45,192 -98.01 4 -99.50 0.0000
2024-03-22 2023-12-31 13F/A-1 INNOVIVA COM 45781M101 45,040 722
2024-02-09 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 917 -45,192 4 0.0000
2024-02-09 2023-12-31 13F INNOVIVA COM 45781M101 45,040 -1,069 722 0.0001
2023-11-13 2023-09-30 13F INNOVIVA COM 45781M101 46,109 1,234 2.75 599 4.73 0.0005
2023-08-11 2023-06-30 13F INNOVIVA COM 45781M101 44,875 1,672 3.87 571 17.49 0.0005
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 43,203 -22,397 -34.14 486 -44.07 0.0004
2023-02-10 2022-12-31 13F INNOVIVA COM 45781M101 65,600 2,532 4.01 869 18.55 0.0008
2022-11-10 2022-09-30 13F INNOVIVA COM 45781M101 63,068 8,946 16.53 733 -8.15 0.0008
2022-08-12 2022-06-30 13F INNOVIVA COM 45781M101 54,122 8,651 19.03 798 -9.22 0.0008
2022-05-12 2022-03-31 13F INNOVIVA COM 45781M101 45,471 -6,752 -12.93 879 -2.55 0.0008
2022-02-11 2021-12-31 13F INNOVIVA COM 45781M101 52,223 3,155 6.43 902 9.87 0.0007
2021-11-05 2021-09-30 13F INNOVIVA I Common Stock 45781M101 49,068 4,965 11.26 821 38.92 0.0008
2021-08-06 2021-06-30 13F INNOVIVA COM 45781M101 44,103 14,608 49.53 591 67.90 0.0005
2021-05-07 2021-03-31 13F INNOVIVA COM 45781M101 29,495 17,844 153.15 352 144.44 0.0003
2021-02-12 2020-12-31 13F INNOVIVA COM 45781M101 11,651 7,941 214.04 144 278.95 0.0001
2020-11-06 2020-09-30 13F INNOVIVA COM 45781M101 3,710 -452 -10.86 38 -34.48 0.0000
2020-08-28 2020-06-30 13F/A-1 INNOVIVA COM 45781M101 4,162 -801 -16.14 58 -1.69 0.0001
2020-08-07 2020-06-30 13F INNOVIVA COM 45781M101 4,162 -801 58 12.0430
2020-05-08 2020-03-31 13F INNOVIVA COM 45781M101 4,963 1,080 27.81 59 5.36 0.0001
2020-02-07 2019-12-31 13F INNOVIVA COM 45781M101 3,883 2,113 119.38 56 211.11 0.0001
2019-11-08 2019-09-30 13F INNOVIVA COM 45781M101 1,770 -2,038 -53.52 18 -67.27 0.0000
2019-08-09 2019-06-30 13F INNOVIVA COM 45781M101 3,808 -102,574 -96.42 55 -96.31 0.0001
2019-05-10 2019-03-31 13F INNOVIVA COM 45781M101 106,382 -11,817 -10.00 1,492 -27.68 0.0015
2019-02-08 2018-12-31 13F INNOVIVA COM 45781M101 118,199 115,599 4,446.12 2,063 4,931.71 0.0023
2018-11-09 2018-09-30 13F INNOVIVA COM 45781M101 2,600 -178,460 -98.56 41 -98.36 0.0000
2018-08-10 2018-06-30 13F INNOVIVA COM 45781M101 181,060 -247,029 -57.71 2,498 -65.00 0.0025
2018-05-11 2018-03-31 13F INNOVIVA COM 45781M101 428,089 425,872 19,209.38 7,137 22,922.58 0.0070
2018-02-09 2017-12-31 13F INNOVIVA COM 45781M101 2,217 546 32.68 31 29.17 0.0000
2017-11-13 2017-09-30 13F INNOVIVA COM 45781M101 1,671 1,077 181.31 24 200.00 0.0000
2017-08-11 2017-06-30 13F INNOVIVA COM 45781M101 594 220 58.82 8 60.00 0.0000
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 374 353 1,680.95 5 0.0000
2017-02-10 2016-12-31 13F INNOVIVA COM 45781M101 21 21 0 0.0000
2016-11-04 2016-09-30 13F INNOVIVA COM 45781M101 0 -479 -100.00 0 -100.00
2016-08-05 2016-06-30 13F INNOVIVA COM 45781M101 479 -19 -3.82 5 -16.67 0.0000
2016-05-06 2016-03-31 13F INNOVIVA COM 45781M101 498 17 3.53 6 20.00 0.0000
2016-02-05 2015-12-31 13F THERAVANCE COM 88338T104 481 0 0.00 5 66.67 0.0000
2015-11-06 2015-09-30 13F THERAVANCE COM 88338T104 481 16 3.44 3 -62.50 0.0000
2015-08-05 2015-06-30 13F THERAVANCE COM 88338T104 465 213 84.52 8 100.00 0.0000
2015-05-08 2015-03-31 13F THERAVANCE COM 88338T104 252 0 0.00 4 0.00 0.0000
2015-02-06 2014-12-31 13F/A-1 THERAVANCE COM 88338T104 252 -748 -74.80 4 -77.78 0.0000
2015-02-06 2014-12-31 13F THERAVANCE COM 88338T104 252 4
2014-11-07 2014-09-30 13F THERAVANCE COM 88338T104 1,000 0 0.00 18 -40.00 0.0000
2014-08-08 2014-06-30 13F THERAVANCE COM 88338T104 1,000 -272 -21.38 30 -21.05 0.0000
2014-05-09 2014-03-31 13F THERAVANCE COM 88338T104 1,272 -45 -3.42 38 -19.15 0.0000
2014-02-07 2013-12-31 13F THERAVANCE COM 88338T104 1,317 317 31.70 47 17.50 0.0001
2013-11-01 2013-09-30 13F THERAVANCE COM 88338T104 1,000 400 66.67 40 66.67 0.0001
2013-08-02 2013-06-30 13F THERAVANCE COM 88338T104 600 600 24 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.